These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37751826)

  • 21. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
    Figueiredo P; Lepland A; Scodeller P; Fontana F; Torrieri G; Tiboni M; Shahbazi MA; Casettari L; Kostiainen MA; Hirvonen J; Teesalu T; Santos HA
    Acta Biomater; 2021 Oct; 133():231-243. PubMed ID: 33011297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy.
    Zhang X; Yi C; Zhang L; Zhu X; He Y; Lu H; Li Y; Tang Y; Zhao W; Chen G; Wang C; Huang S; Ouyang G; Yu D
    Acta Biomater; 2023 Mar; 159():338-352. PubMed ID: 36669551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy.
    Fang Z; Lin L; Li Z; Gu L; Pan D; Li Y; Chen J; Ding H; Tian X; Gong Q; Luo K
    Acta Biomater; 2023 Jul; 164():422-434. PubMed ID: 37088159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses.
    Liu X; Feng Z; Wang C; Su Q; Song H; Zhang C; Huang P; Liang XJ; Dong A; Kong D; Wang W
    Biomaterials; 2020 Feb; 230():119649. PubMed ID: 31791843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered macrophage-derived cellular vesicles for NIR-II fluorescence imaging-guided precise cancer photo-immunotherapy.
    Lin Q; Wang Y; Wang L; Fan Z
    Colloids Surf B Biointerfaces; 2024 Mar; 235():113770. PubMed ID: 38330689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment.
    Wen Y; Chen X; Zhu X; Gong Y; Yuan G; Qin X; Liu J
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):43393-43408. PubMed ID: 31701733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-L1 Blockade Peptide-Modified Polymeric Nanoparticles for Oxygen-Independent-Based Hypoxic Tumor Photo/Thermodynamic Immunotherapy.
    Gu X; Wu B; Feng G; Chen Z; Ren F; Chen X; Hong W; Li W
    Mol Pharm; 2023 Aug; 20(8):4007-4020. PubMed ID: 37427910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxymethylated Alginate-Resiquimod Micelles Reverse the Immunosuppressive Tumor Microenvironment and Synergistically Enhance the Chemotherapy and Immunotherapy for Gastric Cancer.
    Chen J; Liu X; Zhao S; Chen H; Lu T; Wang J; Han J; Wu W; Shen X; Li C
    ACS Appl Mater Interfaces; 2023 Aug; 15(30):35999-36012. PubMed ID: 37477904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.
    Yang S; Shim MK; Kim WJ; Choi J; Nam GH; Kim J; Kim J; Moon Y; Kim HY; Park J; Park Y; Kim IS; Ryu JH; Kim K
    Biomaterials; 2021 May; 272():120791. PubMed ID: 33831739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy.
    Wang Y; Wang Z; Chen B; Yin Q; Pan M; Xia H; Zhang B; Yan Y; Jiang Z; Zhang Q; Wang Y
    Nano Lett; 2021 May; 21(10):4371-4380. PubMed ID: 33984236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Three-In-One Assembled Nanoparticle Containing Peptide-Radio-Sensitizer Conjugate and TLR7/8 Agonist Can Initiate the Cancer-Immunity Cycle to Trigger Antitumor Immune Response.
    Zhu X; Wang X; Li B; Zhang Y; Chen Y; Zhang W; Wang Y; Zhai W; Liu Z; Liu S; Sun J; Chen Z; Gao Y
    Small; 2022 May; 18(20):e2107001. PubMed ID: 35434938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic immunotherapy with a calcium-based nanoinducer: evoking pyroptosis and remodeling tumor-associated macrophages for enhanced antitumor immune response.
    Cheng F; He L; Wang J; Lai L; Ma L; Qu K; Yang Z; Wang X; Zhao R; Weng L; Wang L
    Nanoscale; 2024 Oct; 16(39):18570-18583. PubMed ID: 39291343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle-integrated dissolving microneedles for the co-delivery of R848/aPD-1 to synergistically reverse the immunosuppressive microenvironment of triple-negative breast cancer.
    Huang S; Wen T; Wang J; Wei H; Xiao Z; Li B; Shuai X
    Acta Biomater; 2024 Mar; 176():344-355. PubMed ID: 38244662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photothermal MnO
    Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
    Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
    Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat-Confined Tumor-Docking Reversible Thermogel Potentiates Systemic Antitumor Immune Response During Near-Infrared Photothermal Ablation in Triple-Negative Breast Cancer.
    Revuri V; Rajendrakumar SK; Park MS; Mohapatra A; Uthaman S; Mondal J; Bae WK; Park IK; Lee YK
    Adv Healthc Mater; 2021 Nov; 10(21):e2100907. PubMed ID: 34541833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
    Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
    Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer.
    Wang M; Li Y; Wang M; Liu K; Hoover AR; Li M; Towner RA; Mukherjee P; Zhou F; Qu J; Chen WR
    Acta Biomater; 2022 Jan; 138():453-462. PubMed ID: 34757232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered nanomaterials for synergistic photo-immunotherapy.
    Guo R; Wang S; Zhao L; Zong Q; Li T; Ling G; Zhang P
    Biomaterials; 2022 Mar; 282():121425. PubMed ID: 35217344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.